CD123-Directed Bispecific Antibodies for Targeting MDS Clones and Immunosuppressive Myeloid-Derived Suppressor Cells (MDSC) in High-Risk Adult MDS Patients

There is an urgent need to identify effective strategies to prevent leukemic transformation and induce sustained deep remissions in adult high-risk myelodysplastic syndrome (MDS) patients. This article discusses the clinical impact potential of bispecific antibodies (BiAB) capable of redirecting hos...

Descripción completa

Detalles Bibliográficos
Autores principales: Uckun, Fatih M., Watts, Justin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Aging
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9261311/
https://www.ncbi.nlm.nih.gov/pubmed/35822053
http://dx.doi.org/10.3389/fragi.2021.757276
_version_ 1784742245061099520
author Uckun, Fatih M.
Watts, Justin
author_facet Uckun, Fatih M.
Watts, Justin
author_sort Uckun, Fatih M.
collection PubMed
description There is an urgent need to identify effective strategies to prevent leukemic transformation and induce sustained deep remissions in adult high-risk myelodysplastic syndrome (MDS) patients. This article discusses the clinical impact potential of bispecific antibodies (BiAB) capable of redirecting host T-cell cytotoxicity in an MHC-independent manner to malignant clones as well as immunosuppressive myeloid-derived suppressor cells (MDSC) as a new class of anti-MDS drug candidates. T-cell engaging BiAB targeting the CD123 antigen may help delay disease progression in high-risk adult MDS and potentially reduce the risk of transformation to secondary AML.
format Online
Article
Text
id pubmed-9261311
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-92613112022-07-11 CD123-Directed Bispecific Antibodies for Targeting MDS Clones and Immunosuppressive Myeloid-Derived Suppressor Cells (MDSC) in High-Risk Adult MDS Patients Uckun, Fatih M. Watts, Justin Front Aging Aging There is an urgent need to identify effective strategies to prevent leukemic transformation and induce sustained deep remissions in adult high-risk myelodysplastic syndrome (MDS) patients. This article discusses the clinical impact potential of bispecific antibodies (BiAB) capable of redirecting host T-cell cytotoxicity in an MHC-independent manner to malignant clones as well as immunosuppressive myeloid-derived suppressor cells (MDSC) as a new class of anti-MDS drug candidates. T-cell engaging BiAB targeting the CD123 antigen may help delay disease progression in high-risk adult MDS and potentially reduce the risk of transformation to secondary AML. Frontiers Media S.A. 2021-09-27 /pmc/articles/PMC9261311/ /pubmed/35822053 http://dx.doi.org/10.3389/fragi.2021.757276 Text en Copyright © 2021 Uckun and Watts. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Aging
Uckun, Fatih M.
Watts, Justin
CD123-Directed Bispecific Antibodies for Targeting MDS Clones and Immunosuppressive Myeloid-Derived Suppressor Cells (MDSC) in High-Risk Adult MDS Patients
title CD123-Directed Bispecific Antibodies for Targeting MDS Clones and Immunosuppressive Myeloid-Derived Suppressor Cells (MDSC) in High-Risk Adult MDS Patients
title_full CD123-Directed Bispecific Antibodies for Targeting MDS Clones and Immunosuppressive Myeloid-Derived Suppressor Cells (MDSC) in High-Risk Adult MDS Patients
title_fullStr CD123-Directed Bispecific Antibodies for Targeting MDS Clones and Immunosuppressive Myeloid-Derived Suppressor Cells (MDSC) in High-Risk Adult MDS Patients
title_full_unstemmed CD123-Directed Bispecific Antibodies for Targeting MDS Clones and Immunosuppressive Myeloid-Derived Suppressor Cells (MDSC) in High-Risk Adult MDS Patients
title_short CD123-Directed Bispecific Antibodies for Targeting MDS Clones and Immunosuppressive Myeloid-Derived Suppressor Cells (MDSC) in High-Risk Adult MDS Patients
title_sort cd123-directed bispecific antibodies for targeting mds clones and immunosuppressive myeloid-derived suppressor cells (mdsc) in high-risk adult mds patients
topic Aging
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9261311/
https://www.ncbi.nlm.nih.gov/pubmed/35822053
http://dx.doi.org/10.3389/fragi.2021.757276
work_keys_str_mv AT uckunfatihm cd123directedbispecificantibodiesfortargetingmdsclonesandimmunosuppressivemyeloidderivedsuppressorcellsmdscinhighriskadultmdspatients
AT wattsjustin cd123directedbispecificantibodiesfortargetingmdsclonesandimmunosuppressivemyeloidderivedsuppressorcellsmdscinhighriskadultmdspatients

Ejemplares similares